Arrayit is a leading life sciences company providing
innovative products and services to empower exploration of the human genome, as
well as the genomes of plants and animals. The company’s patented microarray
manufacturing platform and proprietary VIP™ genotyping technology are used in a
wide variety of research centers around the world – including research
laboratories, pharmaceutical businesses, universities, biotechnology firms,
hospitals, government agencies and nonprofit research organizations. By
developing and commercializing technology that provides novel insights into the
function of genes and proteins, Arrayit opens the door for improved disease
diagnostics, safer medicines and more nutritional crop plants.
Since 1999, the company has built a powerful portfolio of
intellectual property that includes more than 650 life sciences products. In
total, Arrayit’s products and services, which are used in the life sciences,
pharmaceutical and diagnostics markets, account for an estimated $690 billion
in annual revenue. In May, the company built on its strong industry performance
by teaming with Vivos on its Global Genome Vault, the only private human DNA
vault on Earth. Through this partnership, Arrayit will optimize Vivos’s DNA
collection efforts by providing its innovative blood card technology, which
allows for the rapid collection, separation, drying and storage of human
genomic DNA in a format that is both permanent and highly miniaturized.
“We are pleased to partner with Vivos on this ambitious
scientific project,” Rene Schena, chief executive officer of Arrayit, stated in
a news release. “Rapid advances in biomedical research offer the promise of
future scientific breakthroughs based on high quality archival genomic DNA.”
In recent months, the company has utilized the marketability
of its products and services to realize strong financial results. In 2014,
Arrayit recorded a 128 percent increase in annual gross profit, demonstrating
the immense market potential of its groundbreaking offerings. Look for Arrayit
to continue leveraging its diverse product portfolio in the future, providing a
platform for sustainable industry growth.
For prospective shareholders, Arrayit’s extensive customer
base, which spans more than 50 countries, and innovative portfolio of products
and services make the company an intriguing investment opportunity. Look for
Arrayit to continue utilizing its proprietary microarray platform in order to
expand its market share in the genetic research, pharmaceutical and diagnostic
communities moving forward.
For more information, visit www.arrayit.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment